37 96
Study
concept
and
design:
De Nunzio,
Thompson,
Andriole,
Freedland.
Acquisition
of
data:
De Nunzio.
Analysis
and
interpretation
of
data:
De Nunzio.
Drafting
of
the manuscript:
De Nunzio.
Critical
revision
of
the
manuscript
for
important
intellectual
content:
Thompson,
Andriole,
Freedland.
Statistical
analysis:
None.
Obtaining
funding:
None.
Administrative,
technical,
or material
support:
[last
name
or
names—or
None].
Supervision:
Thompson,
Andriole,
Freedland.
Other
(specify): None.
Financial
disclosures:
Cosimo
De
Nunzio
certifies
that
all
conflicts
of
interest,
including
specific
financial
interests
and
relationships
and
affiliations
relevant
to
the
subject matter
or materials
discussed
in
the
manuscript
(eg,
employment/affiliation,
grants
or
funding,
consultan-
cies, honoraria,
stock
ownership
or options,
expert
testimony,
royalties,
or
patents
filed,
received,
or
pending),
are
the
following: None.
Funding/Support
and
role
of
the
sponsor:
This work was
supported
by
grants
U01CA86402
and
5P30
CA0541474
(I.M.T.)
and
K24CA160653
(S.J.F.).
References
[1]
Alcaraz A, Hammerer P, Tubaro A, Schroder FH, Castro R. Is there evidence of a relationship between benign prostatic hyperplasia and prostate cancer? Findings of a literature review. Eur Urol 2009;55:864–73.
[2]
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010;60:277–300.
[3]
De Marzo AM, Platz EA, Sutcliffe S, et al. Inflammation in prostate carcinogenesis. Nat Rev Cancer 2007;7:256–69.
[4]
De Nunzio C, Aronson W, Freedland SJ, Giovannucci E, Parsons JK. The correlation between metabolic syndrome and prostatic dis- eases. Eur Urol 2012;61:560–70.
[5]
Hsing AW, Sakoda LC, Chua Jr S. Obesity, metabolic syndrome, and prostate cancer. Am J Clin Nutr 2007;86:843–57.
[6]
Buschemeyer III WC, Freedland SJ. Obesity and prostate cancer: epidemiology and clinical implications. Eur Urol 2007;52:331–43.
[7]
Rota M, Scotti L, Turati F, et al. Alcohol consumption and prostate cancer risk: a meta-analysis of the dose-risk relation. Eur J Cancer Prev 2012;21:350–9.
[8]
Xu H, Jiang HW, Ding GX, et al. Diabetes mellitus and prostate cancer risk of different grade or stage: a systematic review and meta-analysis. Diabetes Res Clin Pract 2013;99:241–9.
[9]
Bansal D, Bhansali A, Kapil G, Undela K, Tiwari P. Type 2 diabetes and risk of prostate cancer: a meta-analysis of observational stud- ies. Prostate Cancer ProstaticDis 2013;16:151–8, S1.
[10]
Giovannucci E, Liu Y, Platz EA, Stampfer MJ, Willett WC. Risk factors for prostate cancer incidence and progression in the health profes- sionals follow-up study. Int J Cancer 2007;121:1571–8.[11]
Islami F, Moreira DM, Boffetta P, Freedland SJ. A systematic review and meta-analysis of tobacco use and prostate cancer mortality and incidence in prospective cohort studies. Eur Urol 2014;66: 1054–64.[12]
Pantarotto J, Malone S, Dahrouge S, Gallant V, Eapen L. Smoking is associated with worse outcomes in patients with prostate cancer treated by radical radiotherapy. BJU Int 2007;99:564–9.[13]
Weaver KE, Foraker RE, Alfano CM, et al. Cardiovascular risk factors among long-term survivors of breast, prostate, colorectal, and gynecologic cancers: a gap in survivorship care? J Cancer Surviv 2013;7:253–61.[14]
Visvanathan K, Helzlsouer KJ, Boorman DW, et al. Association among an ornithine decarboxylase polymorphism, androgen re- ceptor gene (CAG) repeat length and prostate cancer risk. J Urol 2004;171:652–5.
[15]
Hultdin J, Van Guelpen B, Bergh A, Hallmans G, Stattin P. Plasma folate, vitamin B12, and homocysteine and prostate cancer risk: a prospective study. Int J Cancer 2005;113:819–24.
[16]
Baglietto L, Severi G, English DR, Hopper JL, Giles GG. Alcohol consumption and prostate cancer risk: results from the Melbourne collaborative cohort study. Int J Cancer 2006;119:1501–4.[17]
Gonzalez A, Peters U, Lampe JW, White E. Boron intake and prostate cancer risk. Cancer Causes Control 2007;18:1131–40.[18]
Rohrmann S, Genkinger JM, Burke A, et al. Smoking and risk of fatal prostate cancer in a prospective U.S. study. Urology 2007;69: 721–5.[19]
Smit E, Garcia-Palmieri MR, Figueroa NR, et al. Protein and legume intake and prostate cancer mortality in Puerto Rican men. Nutr Cancer 2007;58:146–52.
[20]
Butler LM, Wang R, Wong AS, Koh WP, Yu MC. Cigarette smoking and risk of prostate cancer among Singapore Chinese. Cancer Causes Control 2009;20:1967–74.[21]
Watters JL, Park Y, Hollenbeck A, Schatzkin A, Albanes D. Cigarette smoking and prostate cancer in a prospective US cohort study. Cancer Epidemiol Biomarkers Prev 2009;18:2427–35.[22]
Batty GD, Kivimaki M, Clarke R, Davey SG, Shipley MJ. Modifiable risk factors for prostate cancer mortality in London: forty years of follow-up in the Whitehall study. Cancer Causes Control 2011;22: 311–8.[23]
Grundmark B, Zethelius B, Garmo H, Holmberg L. Serum levels of selenium and smoking habits at age 50 influence long term pros- tate cancer risk; a 34 year ULSAM follow-up. BMC Cancer 2011; 11:431.[24]
Geybels MS, Verhage BA, van Schooten FJ, van den Brandt PA. Measures of combined antioxidant and pro-oxidant exposures and risk of overall and advanced stage prostate cancer. Ann Epi- demiol 2012;22:814–20.[25]
Karlsen RV, Bidstrup PE, Christensen J, et al. Men with cancer change their health behaviour: a prospective study from the Danish diet, cancer and health study. Br J Cancer 2012;107:201–6.[26]
Karppi J, Kurl S, Laukkanen JA, Kauhanen J. Serum beta-carotene in relation to risk of prostate cancer: the Kuopio Ischaemic Heart Disease Risk Factor study. Nutr Cancer 2012;64:361–7.
[27]
Shafique K, McLoone P, Qureshi K, Leung H, Hart C, Morrison DS. Coffee consumption and prostate cancer risk: further evidence for inverse relationship. Nutr J 2012;11:42.[28]
Tseng CH. Insulin use is not significantly predictive for prostate cancer mortality in diabetic patients: a 12-year follow-up study. BJU Int 2012;110:668–73.[29]
Bae JM, Li ZM, Shin MH, KimDH, Lee MS, Ahn YO. Cigarette smoking and prostate cancer risk: negative results of the Seoul Male Cancer Cohort Study. Asian PacJ Cancer Prev 2013;14:4667–9.[30]
Heikkila K, Nyberg ST, Theorell T, et al. Work stress and risk of cancer: meta-analysis of 5700 incident cancer events in 116,000 European men and women. BMJ 2013;346:f165.[31]
Koutros S, Meyer TE, Fox SD, et al. Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorec- tal and Ovarian Cancer Screening Trial. Carcinogenesis 2013;34: 2281–5.[32]
Lemogne C, Consoli SM, Melchior M, et al. Depression and the risk of cancer: a 15-year follow-up study of the GAZEL cohort. Am J Epidemiol 2013;178:1712–20.[33]
Onitilo AA, Berg RL, Engel JM, et al. Prostate cancer risk in pre- diabetic men: a matched cohort study. Clin Med Res 2013;11: 201–9.E U R O P E A N
U R O L O G Y
F O C U S
1
( 2 0 1 5
)
2 8 – 3 8
37